Tacalcitol ointment — Competitive Intelligence Brief

Tacalcitol ointment (Tacalcitol ointment) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Vitamin D analog. Area: Dermatology.

phase 3 Vitamin D analog Vitamin D receptor Dermatology Small molecule

Target snapshot

Tacalcitol ointment (Tacalcitol ointment) — LEO Pharma. Tacalcitol ointment is a synthetic vitamin D3 analog that modulates the vitamin D receptor.

Comparator set (6 drugs)

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
Tacalcitol ointment TARGET	Tacalcitol ointment	LEO Pharma	phase 3	Vitamin D analog	Vitamin D receptor
Cholecalciferol 12 000 UI	Cholecalciferol 12 000 UI	Assistance Publique - Hôpitaux de Paris	marketed	Vitamin D supplement	Vitamin D receptor (VDR)
Calcifediol Oral Product	Calcifediol Oral Product	OPKO Health, Inc.	marketed	Vitamin D analog	Vitamin D receptor (VDR)
Calcitriol (Rocaltrol®)	Calcitriol (Rocaltrol®)	Joslin Diabetes Center	marketed	Vitamin D analog	Vitamin D receptor (VDR)
calcipotriol hydrate [Daivonex]	calcipotriol hydrate [Daivonex]	Hoffmann-La Roche	marketed	Vitamin D3 analog	Vitamin D receptor (VDR)
ibandronate, calcium and vitamin D	ibandronate, calcium and vitamin D	Charite University, Berlin, Germany	marketed	Bisphosphonate combination therapy	Farnesyl pyrophosphate synthase (ibandronate); calcium-sensing receptor and vitamin D receptor (supportive agents)
Vitamin D: liquid form, start monthly	Vitamin D: liquid form, start monthly	University Hospital, Basel, Switzerland	marketed	Vitamin/steroid hormone	Vitamin D receptor (VDR)

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Vitamin D analog class)

1. LEO Pharma · 2 drugs in this class
2. Genzyme, a Sanofi Company · 2 drugs in this class
3. National Cancer Institute, Naples · 2 drugs in this class
4. OPKO Health, Inc. · 2 drugs in this class
5. Joslin Diabetes Center · 1 drug in this class
6. Kyowa Kirin, Inc. · 1 drug in this class
7. Maimónides Biomedical Research Institute of Córdoba · 1 drug in this class
8. Shanghai Jiao Tong University Affiliated Sixth People's Hospital · 1 drug in this class
9. Shiraz University of Medical Sciences · 1 drug in this class
10. St. Justine's Hospital · 1 drug in this class